-
meps.ahrq.gov/data_files/publications/st347/stat347.shtml
November 01, 2011 - STATISTICAL BRIEF #347:
Trends in Hormone Replacement Therapy Drugs Utilization and Expenditures …
STATISTICAL BRIEF #347:
Trends in Hormone Replacement Therapy Drugs … 2008, inflation adjusted total expenditures for outpatient prescription hormone replacement therapy drugs … Between 2001 and 2008 utilization of outpatient prescription hormone replacement therapy drugs by adult … the number of adult women obtaining one or more outpatient prescription hormone replacement therapy drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
April 01, 2013 - or approved versus off-label
drugs. … Discussion
All approved drugs, some off-label beta blockers, and
the angiotensin inhibiting drugs were … The relative effect size of drugs was
moderate: drugs would result in to 200 to 400 cases of
clinical … or approved versus off-label
drugs. … Modeling choice
behavior for new pharmaceutical products.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine-adults-executive-130408.pdf
April 01, 2013 - or approved versus off-label
drugs. … Discussion
All approved drugs, some off-label beta blockers, and
the angiotensin inhibiting drugs were … The relative effect size of drugs was
moderate: drugs would result in to 200 to 400 cases of
clinical … or approved versus off-label
drugs. … Modeling choice
behavior for new pharmaceutical products.
-
meps.ahrq.gov/data_files/publications/workingpapers/wp_12006.pdf
November 01, 2012 - Identifying the fastest growing categories of drugs, where drugs are grouped into clinically
relevant … (e.g., cardiovascular drugs). … Psychotherapeutic Drugs
In 2007/08, psychotherapeutic drugs were the largest class of drugs among … Cardiovascular Drugs
Cardiovascular drugs were the second largest class of drugs among the noninstitutionalized … Central Nervous System (CNS) Drugs
Expenditures for CNS drugs, the third largest class of drugs in
-
hcup-us.ahrq.gov/reports/statbriefs/sb247-appendix.pdf
January 14, 2019 - by sulfonamides, intentional self-harm, initial encounter
T37.1X2A Poisoning by antimycobacterial drugs … , intentional self-harm, initial encounter
T37.2X2A Poisoning by antimalarials and drugs acting on … blood protozoa, intentional self-harm, initial encounter
T37.3X2A Poisoning by other antiprotozoal drugs … , intentional self-harm, initial encounter
T38.3X2A Poisoning by insulin and oral hypoglycemic drugs … acting on muscles, intentional self-harm, initial encounter
T48.292A Poisoning by other drugs acting
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-risk-drugs-protocol.pdf
July 27, 2023 - Center Rapid Response Protocol
Project Title: Making Healthcare Safer IV:
Protocols for High-Risk Drugs … The “Protocols for High-Risk Drugs:
Reducing Adverse Drug Events Related to Anticoagulants” as a patient … High-Alert Drugs: Patient Safety Practices for
Intravenous Anticoagulants.
-
psnet.ahrq.gov/node/60259/psn-pdf
April 22, 2020 - Spikes in demand from coronavirus patients are creating
shortages of asthma drugs and sedatives for … https://psnet.ahrq.gov/issue/spikes-demand-coronavirus-patients-are-creating-shortages-asthma-drugs- … https://psnet.ahrq.gov/issue/spikes-demand-coronavirus-patients-are-creating-shortages-asthma-drugs-and-sedatives … https://psnet.ahrq.gov/issue/spikes-demand-coronavirus-patients-are-creating-shortages-asthma-drugs-and-sedatives
-
meps.ahrq.gov/data_files/publications/st271/sb271.xml
December 01, 2009 - STATISTICAL BRIEF #271
December 2009
Trends in Outpatient Prescription Thyroid Drugs Purchases … Stagnitti, MPA
Highlights
From 1996 to 2007, total expenditures for prescription thyroid drugs … When comparing 1996 and 2007, the total number of prescription purchases of thyroid drugs for adults … were included in the therapeutic subclass thyroid drugs. … of drugs.
-
effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards
March 09, 2010 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … Research Protocol
Archived
The Effectiveness of Disease-Modifying Antirheumatic Drugs … September 26, 2011
Systematic Review
Archived
Disease-Modifying Antirheumatic Drugs
-
hcup-us.ahrq.gov/toolssoftware/chronic_icd10/CCIR-ChangeLog-v20241-v20251.xlsx
November 01, 2024 - R4185 Anosognosia 1 Chronic
T45AX1A Poisoning by immune checkpoint inhibitors and immunostimulant drugs … , sequela 0 Not chronic
T45AX5A Adverse effect of immune checkpoint inhibitors and immunostimulant drugs … encounter 0 Not chronic
T45AX5D Adverse effect of immune checkpoint inhibitors and immunostimulant drugs … encounter 0 Not chronic
T45AX5S Adverse effect of immune checkpoint inhibitors and immunostimulant drugs … , sequela 0 Not chronic
T45AX6A Underdosing of immune checkpoint inhibitors and immunostimulant drugs
-
effectivehealthcare-admin.ahrq.gov/products/horizon-scan/research-2015
November 01, 2017 - Health care horizon scanning is an activity undertaken to identify technological and system innovations (pharmaceuticals … New drugs for treating one disease—direct-acting oral antivirals for interferon-free treatment of hepatitis … When considering categories of these interventions, such as drugs, devices, and procedures, new pharmaceuticals … /biotechnologies and new off-label uses of existing pharmaceuticals constituted about 60 percent of estimated … annual spend of more than $1 billion each totaled $35 billion in estimated spend (including the new oral drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness Research,
AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar
drugs in the … Prescription drugs: abuse and addiction.
[internet]. … Titan Pharmaceuticals provides probuphine
update after meeting with U.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness Research,
AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar
drugs in the … Prescription drugs: abuse and addiction.
[internet]. … Titan Pharmaceuticals provides probuphine
update after meeting with U.S.
-
meps.ahrq.gov/data_files/publications/st407/stat407.pdf
June 01, 2013 - Statistical Brief #407: Trends in Utilization and Expenditures of Prescribed Drugs Treating Diabetes, … and 2010
1
STATISTICAL BRIEF #407
June 2013
Trends in Utilization and Expenditures of Prescribed Drugs … drugs become available. … Trends in Utilization and Expenditures of Prescribed Drugs Treating Diabetes,
Hypertension, and High … Total number of prescribed drug purchases of
anti-diabetic, anti-hypertensive, or statin drugs
for
-
psnet.ahrq.gov/issue/nearly-all-thirty-most-frequently-used-emergency-department-drugs-experienced-shortages-2006
April 27, 2022 - Study
Nearly all thirty most frequently used emergency department drugs experienced … Nearly all thirty most frequently used emergency department drugs experienced shortages from 2006–2019 … Nearly all thirty most frequently used emergency department drugs experienced shortages from 2006–2019 … September 5, 2018
Despite federal legislation, shortages of drugs used in acute care
-
psnet.ahrq.gov/node/46970/psn-pdf
June 27, 2018 - Using drug knowledgebase information to distinguish
between look-alike-sound-alike drugs. … Using drug knowledgebase information to distinguish between
look-alike-sound-alike drugs. … psnet.ahrq.gov/issue/using-drug-knowledgebase-information-distinguish-between-look-alike-sound-
alike-drugs … Look-alike, sound-alike drugs are a known safety risk and contribute to medication errors. … psnet.ahrq.gov/issue/using-drug-knowledgebase-information-distinguish-between-look-alike-sound-alike-drugs
-
digital.ahrq.gov/ndc
January 01, 2023 - are ambiguous; many NDCs can exist for a single product, leading to inaccuracies in the dispensing of drugs … Library of Medicine (NLM) has been working on RxNorm , which provides "standard names for clinical drugs … Background
The National Drug Codes (NDCs) are standards for reporting drugs and biological products … The Drug Listing Act of 1972 requires that all drug-producing establishments report to the FDA all drugs … Only selected non-prescription drugs are included in the NDC database.
-
hcup-us.ahrq.gov/reports/statbriefs/sb158.jsp
July 01, 2013 - system drugs
2.6
0.7
0.7
0.5
Cardiovascular drugs
29.4
7.6
7.5
5.8
Digoxin … 21.4
16.6
Abbreviation: NSAIDS, nonsteroidal anti-inflammatory drugs. … Cardiovascular drugs: 7.5 originated during the stay and 29.4 were present on admission. … Antidepressants, 17.6, Central nervous system drugs, 13.5, Other psychotropic drugs, 9.5, Insulin and … drugs, 5.5.
-
psnet.ahrq.gov/issue/adverse-drug-event-surveillance-and-drug-withdrawals-united-states-1969-2002
October 08, 2014 - than 30 years of collected data, investigators discovered nearly 2.3 million case reports for the 6000 drugs … These reports resulted in additional safety warnings, a greater list of known ADEs with specific drugs … , and a small percentage of drugs pulled from the market. … The authors advocate for continued vigilance and reporting to ensure the safety of drugs prescribed to
-
www.ahrq.gov/news/newsroom/case-studies/cquips0701.html
October 01, 2014 - AHRQ-supported research was influential in revisions to Health Canada's process for approving names for drugs … A drug neighborhood is a group of drugs with similar spellings, pronunciations, or therapeutic uses that … An example of a confusing (or "dense") neighborhood of drugs includes Dynabac, Synalar, Rynatan, Dynacirc … An example of a less confusing (or low density) neighborhood of drugs is the one containing only Flexeril … Notably, commonly prescribed drugs are recognized more accurately than rarely prescribed ones.